Changing factors associated with parent activation after pediatric hematopoietic stem cell transplant by Pennarola, Brian W. et al.
Changing Factors associated with Parent Activation after 
Pediatric Hematopoietic Stem Cell Transplant
Brian W. Pennarola1, Angie Mae Rodday, MS1, Kristin Bingen, PhD2, Lisa A. Schwartz, 
PhD3, Sunita K. Patel, PhD4, Karen L. Syrjala, PhD5, Deborah K. Mayer, PhD, RN6, Sara J. 
Ratichek, MA1, Eva C. Guinan, MD7, Mary Jo Kupst, PhD2, Judith H. Hibbard, PhD8, and 
Susan K. Parsons, MD, MRP1,9 for the HSCT-CHESS™ Study*
Brian W. Pennarola: bwpennarola@gmail.com; Angie Mae Rodday: arodday@tuftsmedicalcenter.org; Kristin Bingen: 
kbingen@mcw.edu; Lisa A. Schwartz: schwartzl@email.chop.edu; Sunita K. Patel: spatel@coh.org; Karen L. Syrjala: 
ksyrjala@fhcrc.org; Deborah K. Mayer: dkmayer@email.unc.edu; Sara J. Ratichek: sjratichek@gmail.com; Eva C. 
Guinan: eva_guinan@dfci.harvard.edu; Mary Jo Kupst: mkupst@mcw.edu; Judith H. Hibbard: judithhibbard@mac.com; 
Susan K. Parsons: sparsons@tuftsmedicalcenter.org
1The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 
USA
2Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
3Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
4Departments of Population Sciences, Pediatrics, and Supportive Care Medicine, City of Hope 
National Medical Center, Duarte, CA, USA
5Department of Biobehavioral Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 
USA
6School of Nursing, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA
7Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/
Oncology, Childrens Hospital, Boston, MA, USA
8Department of Planning, Public Policy and Management, University of Oregon, Eugene, OR, 
USA
9Departments of Medicine and Pediatrics, Tufts University School of Medicine, Boston, MA, USA
Abstract
Purpose—To identify factors associated with parent activation in parents of children undergoing 
pediatric hematopoietic stem cell transplant (HSCT) in the 6 months following HSCT, and to 
address if their association with parent activation changes over time.
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Methods—Measures for this analysis, including the Parent Patient Activation Measure (Parent-
PAM), were completed by parents (N=198) prior to their child’s HSCT preparative regimen and 
again at 6 months post-HSCT. Clinical data were also collected. A repeated measures model was 
built to estimate the association between clinical and demographic factors and parent well-being 
on Parent-PAM scores. Interactions with time were considered to test for changing effects over 
time.
Results—Throughout the HSCT course, older parent age was associated with lower Parent-PAM 
scores (β=−0.29, p=0.02) and never being married was associated with higher scores (versus 
married, β=12.27, p=0.03). While higher parent emotional functioning scores were not associated 
with activation at baseline, they were important at 6 months (baseline: β=−0.002, p=0.96; 
interaction: β=0.14, p=0.03). At baseline longer duration of illness was associated with increased 
activation, but this effect diminished with time (baseline: β=3.29, p=0.0002; interaction: β=−2.40, 
p=0.02). Activation levels dropped for parents of children who went from private to public 
insurance (baseline: β=2.95, p=0.53; interaction: β=−13.82, p=0.004). Clinical events did not 
affect Parent-PAM scores.
Conclusions—Our findings reveal important changes in the factors associated with parent 
activation in the first 6 months after pediatric HSCT. These findings may reflect the emotional and 
financial toll of pediatric HSCT on parent activation.
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INTRODUCTION
Patient activation, defined as an individual’s knowledge, confidence, and ability to manage 
their health or chronic illness [1], is thought to be essential to the delivery of effective care. 
The Chronic Care Model (CCM), developed by Wagner et al. and widely applied to the 
treatment of chronic illnesses, asserts that good clinical outcomes hinge on the exchange 
between an activated patient and a receptive, prepared clinical team [2]. Research in 
chronically-ill populations with diabetes [3], multiple sclerosis [4], cardiovascular 
conditions [5] and healthy adult populations [6,7] has shown associations between higher 
patient activation and better health status, health-related quality of life (HRQL), and 
adherence to healthy behaviors. In pediatrics, studies have highlighted the analogous 
importance of informed and self-efficacious parents in effectively caring for their children. 
Higher parenting self-efficacy (PSE), a related construct, in parents of children receiving 
standard outpatient care [8] or children with sickle cell disease [9], inflammatory bowel 
disease [10], or HIV [11] has been associated with better adherence to medications and 
improved clinical outcomes.
We recently reported on the novel construct of “parent activation” [12], which is defined as 
a parent’s knowledge, confidence, and ability to manage their child’s health or chronic 
illness and extends self-efficacy to self-management. Our analysis focused on parents of 
children who were scheduled to undergo pediatric hematopoietic stem cell transplant 
(HSCT). The relative influence of personal traits of the parent, the social environment 
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surrounding the parent-child relationship, and characteristics of the child on parent 
activation were explored in a multivariable model. Our model revealed that higher parent 
activation at the time of HSCT was significantly associated with higher patient activation 
concerning the parent’s own health, younger parent age, a longer duration of the child’s 
illness, and worse rating of the parent’s own general health. In contrast to other studies of 
the related constructs of patient activation and PSE, no significant associations were 
observed between parent activation and socioeconomic status, family characteristics, or the 
parent’s emotional functioning [12].
Due to the novelty of our first analysis and the divergence between factors associated with 
parent activation and related constructs, we sought to evaluate parent activation 
longitudinally in our pediatric HSCT sample and to identify whether factors associated with 
parent activation change over the HSCT course. Moreover, as identified by Hibbard et al. 
(2007), while an abundance of studies evaluate the longitudinal effects of interventions on 
patient activation [13–15] or PSE [16,17], there is a dearth in the literature concerning the 
potential impact of other factors on changes in activation. Pediatric HSCT, an intensive, 
high-risk treatment regimen that often requires a prolonged hospitalization followed by a 
lengthy recovery, involves substantial fluctuations in daily life, financial resources, and the 
child’s clinical status and, as such, creates an ideal scenario for an in-depth analysis of 
factors that influence parent activation longitudinally. We describe the results of an analysis 
of factors associated with parent activation in parents of children undergoing pediatric 
HSCT using a multivariable repeated measures model.
Based on the results of our previous analysis and those of previous studies of patient 
activation and PSE [12], we conjectured that the multi-faceted demands of the first six 
months post-HSCT would necessitate emotional and environmental resources, not essential 
at baseline, to achieve and/or maintain high parent activation. Therefore, we hypothesized 
several changes in factors associated with parent activation in our sample at baseline versus 
six months. We hypothesized that the effects of parent emotional function and social 
support, changing socioeconomic status, and duration of illness on parent activation would 
change over time. Additionally, we hypothesized that a difficult clinical course for the child 
would result in significantly lower parent activation over time, as evolving medical and 
treatment-related complications might challenge the parent’s knowledge base and 
confidence in managing their child’s health.
METHODS
Participants and Study Procedures
A comprehensive description of study recruitment can be found in our previous paper [12]. 
Briefly, 198 parent-child dyads from six HSCT centers nationwide were enrolled in the 
HSCT-Comprehensive Health Enhancement Support Study (CHESS™) [18,19], a 
randomized controlled trial of a web-based intervention designed to improve the health-
related knowledge, skills, and quality of life of parents of children undergoing HSCT. The 
baseline evaluation was completed prior to the HSCT preparative regimen. Additional 
assessments were collected at 45 days, and 3, 6, 9, and 12 months post-transplant. By 6 
months, 12 children had died and nine had withdrawn from the study. Further, 32 did not 
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complete measures at the 6-month assessment (13 for medical reasons, 17 for non-medical 
reasons, and 2 for unknown reasons) and an additional six parents did not complete the 
primary outcome measure (the Parent-PAM). Therefore, a total of 139 dyads had available 
6-month data.
Measures
Patient Activation Measure (PAM) and Parent PAM—The primary outcome of this 
study was parent activation concerning their child’s health. Parent activation was assessed 
using the Parent-PAM, a modified version of the short form of the PAM [20], which is a 
well-validated measure of patient activation in chronically-ill [1,4,21,22] and healthy adult 
populations [6,15,22]. Both the PAM and Parent-PAM have shown acceptable internal 
consistency reliability (α = 0.86 and α = 0.85, respectively) in this population of parents of 
children undergoing HSCT [12]. The Parent-PAM modifies the items in the PAM to assess 
the parent’s knowledge, confidence, and willingness to act in the context of managing their 
child’s illness. Both measures consist of 13 items scored on a Likert scale with four different 
response options of varying agreement (from 1 = disagree strongly to 4 = agree strongly). 
All responses are summed and scaled from 0–100, based on a conversion chart provided by 
the developers of the measure [23]. This yields a total score where higher scores correspond 
to higher activation. Both PAM and Parent-PAM scores were collected at baseline and 6 
months post-transplant.
Child Health Ratings Inventory –General Health: CHRIs-General—The CHRIs-
General, a well-validated measure of HRQL [24,25] in both children undergoing pediatric 
HSCT and a parent, consists of 20 items, each utilizing a 5-point Likert scale. These items 
assess three domains of general functioning: physical, emotional, and role. A single item 
separately assesses general health. The scores are transformed to a 0–100 point scale, where 
higher scores indicate better functioning and health.
Two different sections of the parental CHRIs-General were completed, one about the 
parent’s own HRQL and another about the child’s HRQL. The CHRIs-General was 
collected at baseline, 45 days, and 3, 6, 9, and 12 months post-transplant. This analysis will 
use the following CHRIs-General scores collected at baseline and 6 months: the parent’s 
rating of their emotional functioning, parent’s rating of their general health, and parent’s 
rating of their child’s general health.
Medical Outcomes Study-Social Support Survey (MOS-SSS)—This 19-item 
validated and reliable questionnaire asks parents to rate their level of access to different 
types of functional support [26]. Parents responded on a 5-point Likert-type scale ranging 
from 1 (none of the time) to 5 (all of the time). A mean score for the overall support score 
was calculated (range, 1–5), where higher scores indicated more frequent availability of 
support. The baseline and 6-month social support score will be used in this analysis.
Demographic Variables—Prior to HSCT, demographic information was obtained from 
parents on the age, gender, and race/ethnicity of both dyad members. Parent participants also 
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supplied information on insurance type, annual household income, job status, and marital 
status. Updates to insurance coverage were elicited from parent participants at 6 months.
Medical Assessment Variables—Baseline medical information was collected by 
trained study staff, using standardized medical chart review forms. Variables included causal 
diagnosis (malignant with or without prior relapse or non-malignant), duration of illness in 
months, and site of pre-HSCT care. Transplant-specific factors included type of HSCT 
(autologous, allogeneic related, allogeneic unrelated) and history of prior HSCT. Acute graft 
versus host disease (aGVHD) and transplant toxicity (as measured by the Bearman toxicity 
scale) [27] were collected at the end of hospitalization, 45 days, and 3 months. Chronic graft 
versus host disease (cGVHD) was collected at the end of hospitalization, 3, 6, and 12 
months. Infection within the previous week was collected at all-time points, using the 
Common Toxicity Criteria of Adverse Events, v. 3.0 [28]. A dichotomous composite 
variable was created to indicate complications during the first 3 months post-HSCT 
(hereafter “early complications”). Early complications was defined as experiencing at least 
one of the following: aGVHD of grade 2 or higher or intermediate or poor toxicity 
(indicating intermediate or high levels of toxicity). A separate dichotomous variable was 
created to indicate the presence of limited or extensive cGVHD by 6 months [29,30]. Any 
systemic infection as defined as the presence of systemic infection by 6 months.
Data Analysis
Baseline demographic and clinical characteristics were described for the study population 
using means (standard deviations (SD)), medians (25th–75th percentile ranges), frequencies 
and percentages. Chi-squared and Fisher’s exact tests (binary or categorical variables) and 
two-sample t-tests (continuous variables) were used to determine if significant associations 
existed between baseline demographic or clinical variables and Parent-PAM completion 
status at 6 months.
Univariate analyses were conducted to assess hypothesized associations between Parent-
PAM score and specific factors. We used maximum likelihood estimation with repeated 
measures (SAS Proc Mixed) to account for the correlations over time with an unstructured 
covariance matrix. Variables that were collected at multiple time periods were allowed to 
change over time within the model. For the duration of illness variable, the natural log 
transformation was used, as the data for duration of illness were not normally distributed. 
Time was an indicator variable for 6 months with baseline as the reference. We 
hypothesized that the relationship between the following variables and Parent-PAM score 
would change between baseline and 6 months: parental emotional functioning; duration of 
illness; early complications; cGVHD; any systemic infection, and drop in insurance (i.e., 
going from private to public insurance). These were tested with interaction terms between 
time and the covariate.
To assess which factors were associated with Parent-PAM scores over time, and to identify 
factors with changing effects on the score over time, a multivariable repeated measures 
model was constructed including univariate significant (p<0.1) covariates and interaction 
terms. Backwards elimination was used to remove variables or interaction terms from that 
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multivariable model that had p>0.05. For the purposes of this analysis, PAM score was 
removed from the model; this prevented self-activation, highly related to the construct of 
parent activation [12], from capturing the variance from all other variables. HSCT-CHESS 
intervention arm was controlled for in the multivariable model. All other variables that were 
significantly associated with Parent-PAM score were tested for collinearity using variance 
inflation factors (VIF).
To address the possibility that Parent-PAM data at 6 months may have been missing not at 
random (MNAR), we stratified the final model by the extent and causes of missing data, 
defining strata as follows: (1) those with missing data due to a medical reason and (2) those 
with complete data or those with missing data not due to a medical reason. The stratified 
models (called pattern mixture models, PMM) [31] assume the data are missing at random 
(MAR) within strata. We compared stratified to unstratified models using likelihood ratio 
tests to assess for the presence of MNAR. Analyses were done using SAS version 9.3 (Cary, 
NC).
RESULTS
Participant and Patient Characteristics
As previously reported [12], our sample included a total of 198 parent-child dyads at 
baseline. Six months after HSCT, the sample included 139 parent-child dyads with 
evaluable Parent-PAM scores. The mean parent age at baseline was 38.5 years (SD=7.9) and 
81.8% were mothers; the mean child age was 8.7 years (SD=5.7) and 43.9% were female 
(Table 1). Parents who completed the 6-month Parent-PAM were more likely to have higher 
incomes (p=0.009) and private insurance at baseline (p=0.0002). There were no other 
differences in demographic or clinical characteristics by completion status.
Over the course of the 6 months post-HSCT 35.3% (n=49) children experienced early 
complications, 18.7% (n=26) developed cGVHD, and 70.5% (n=98) experienced systemic 
infection. Eleven children (7.9%) experienced a drop in their insurance coverage.
Univariate Associations with Parent-PAM Scores Throughout the HSCT Course
Univariate analyses of associations between Parent-PAM score and factors selected by a 
priori hypotheses are summarized in Table 2. Throughout the HSCT course, Parent-PAM 
scores were significantly associated (p<0.1) with time, parent age, marital status, the 
parent’s self-activation (PAM score), causal diagnosis, and HSCT type. Parent education, 
child age, parent general health, and the child’s general health were not associated with 
Parent-PAM scores. Significant interactions were observed between time and each of the 
following variables: parent emotional functioning, log duration of the child’s illness, and 
drop in insurance. In contrast, we did not find significant interactions between time and 
parent social support, early complications, cGVHD, or any systemic infection.
Multivariable Repeated Measures Model for Parent-PAM Scores
Based on backwards elimination criteria, causal diagnosis and HSCT type were removed 
from the multivariable model. Results of the likelihood ratio test comparing the PMM to the 
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repeated measures model did not indicate the presence of MNAR (χ2 (11)=14.1, p=0.28); 
beta estimates and standard errors for the final model are based on the multivariable 
repeated measures model. There was no indication of colllinearity in the model (all 
VIFs<2.0).
Parent age and marital status had constant effects on Parent-PAM scores over time, while 
the effects of parent emotional functioning, duration of illness, and drop in insurance 
changed over time as indicated by significant interactions with time (Table 2, Figure 1). 
Throughout the HSCT course, older parent age (β=−0.29, p=0.02) was associated with lower 
Parent-PAM scores, while higher Parent-PAM scores were significantly associated with 
never being married (vs. married, β=12.27, p=0.03). Higher parent emotional functioning 
scores were not associated with activation at baseline, but became important at 6 months 
(baseline: β=−0.002, p=0.96; interaction: β=0.14, p=0.03). At baseline longer duration of 
illness was associated with increased activation, but this effect diminished over time 
(baseline: β=3.29, p=0.0002; interaction: β=−2.40, p=0.02). Activation levels dropped for 
parents of children who went from private to public insurance (baseline: β=2.95, p=0.53; 
interaction: β=−13.82, p=0.004).
DISCUSSION
Our repeated measures model revealed the dynamic nature of factors associated with parent 
activation (as measured by the Parent-PAM) in the first six months following HSCT. The 
effects of parent age and marital status on Parent-PAM score were consistent over time. 
However, we found that parent’s emotional functioning, length of the child’s illness, and 
changing insurance status affected Parent-PAM scores differently at six months compared to 
baseline.
The association over time between higher parent activation and younger parent age was 
hypothesized, as an analogous relationship was observed in another study of patient 
activation in healthy adults [22]. Older parents may have learned that there are aspects of 
life that are beyond their control and this may temper their assessment of their role as a 
parent caregiver. Younger parents, on the other hand, may be more optimistic in their 
assessment.
Previous studies have not identified an association between higher activation and never 
being married. The results from other studies on the relationship between marital status and 
self-management or self-efficacy are mixed. Some studies have outlined associations 
between being married and better self-management of various chronic diseases [32,33], 
whereas other studies have found higher self-efficacy among patients who were unmarried 
[34] or divorced [35]. Still other studies have found no association between marital status 
and the self-management of chronic illnesses [36,37]. Although never married individuals 
consistently reported higher parent activation scores in our sample, these findings should be 
interpreted with caution given the small number of parents in this group (n=8). One possible 
explanation of this relationship is that never married parents know that they will need 
others’ support to get through transplant and can carefully select who they can rely on and 
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trust. In contrast, married parents may think that they can rely on their partner, but their 
partner may not always provide the needed support.
Changes in other factors associated with parent activation may reflect the impact of the 
child’s transplant on a parent’s knowledge, confidence, and ability to take action on behalf 
of the child’s care over time. Six months post-HSCT, this impact was made evident by the 
emergence of factors related to the challenges and unpredictability of HSCT, such as 
parent’s emotional functioning. This observation is supported by multiple studies that 
describe positive associations between emotional functioning and activated behaviors in 
both adult patients [1,21] and parents of chronically-ill children [38]; it may suggest that 
parents who feel more capable of coping with the difficulties of their child’s illness over 
time may also feel more capable of managing their child’s health state.
The association observed at baseline between the duration of the child’s illness prior to 
HSCT and parent activation was attenuated at six months. While past experiences with 
illness management may translate to relatively higher levels of parent activation at the time 
of transplant, as all parents proceed through the HSCT treatment and recovery, they 
encounter the novel difficulties of HSCT, which may challenge activation. Moreover, longer 
duration in the more chronic phases of illness has been associated with worse parental 
functioning, at least partially explained by the relentlessness of necessary vigilance and the 
toll of unexpected complications or exacerbations [39]. Although duration of illness and 
causal diagnosis may be associated in some cases (e.g., newly acquired aplastic anemia 
versus multiply relapsed ALL), there are many instances where duration of illness can be 
similar between for malignancies and non-malignancies. It is important to understand what 
each child and family is dealing with and what supports the family needs to meet the 
caregiving demands.
The significant interaction between time and changing from private to public insurance at 
six months indicates that insurance change is related to lower parent activation scores. While 
previous studies of pediatric care have described the pernicious effect of losing insurance on 
worsened parent management [40,41], we are unaware of studies that link the change in 
insurance to altered parenting behaviors. These results suggest that changing from private to 
public insurance may negatively influence a parent’s perception of their ability to manage 
their child’s illness. Within the US healthcare system, changing from private to public 
insurance may be associated with worsening severity of disease (related to the Medicaid 
Spend Down) or changes in employment and the resulting loss of private insurance. 
However, with the health insurance reforms resulting from the Affordable Care Act, 
dropping from private to public insurance will be less of an issue going forward as spending 
caps are eliminated [42].
Many of the factors we hypothesized would be associated with parent activation were not 
significantly related to the construct. As summarized in our baseline analysis [12], previous 
studies have outlined relationships between patient activation and general health, education, 
and insurance status, while studies of PSE have outlined associations between PSE, the 
child’s age, and the child’s general health. We found no significant associations between 
parent activation and any of these factors before or at 6 months after HSCT. Our analysis 
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also found no relationship between social support and parent activation, although a recent 
study reported that individuals with diabetes who reported stronger structural and functional 
support networks scored higher on the PAM [43]. These discrepancies may reflect 
differences in factors associated with activation on one’s own health versus activation on 
behalf of one’s child’s health. Further studies are needed to understand the relationship 
between parent activation and types of social support and other factors.
Additionally, no variables directly pertaining to the difficulty of the HSCT recipient’s 
clinical course were significantly associated with parent activation in our final model. In 
univariate analysis, neither early complications nor cGVHD was not associated with lower 
parent activation. Acute and chronic GVHD have been shown to be associated with 
significantly worse HRQL in both adult and pediatric recipients [44,45]. Although we 
hypothesized that clinical complication of HSCT would challenge a parent’s confidence in 
their ability to care for their child post-HSCT and require adaptation to a novel management 
paradigm, we were surprised by its lack of effect on parent activation. As a gap in the 
literature exists concerning the impact of a changing clinical course on activation, we feel 
further studies are needed to understand the relationship between important clinical events 
and both patient and parent activation.
Over time, unrelated donor transplants and other alternative donors have become more 
common, reflecting an increase in the donor pool as well as increased comfort and success 
in applying this treatment to children with malignant and non-malignant conditions. 
However, complications (e.g., GVHD) are higher in the unrelated donor setting than in the 
autologous setting. Our prior work shows that parent emotional functioning is adversely 
affected by transplant complications [46]. The current analysis shows that parent activation 
is adversely affected by longer duration of illness in addition to discrete complications. In 
combination, these data suggest that parents’ ability to maintain their own functioning and 
caregiving role is compromised when faced with the child’s continued health threats and 
complications. Even though these parents may seem as the “experienced” ones, they still 
need our continued support.
We acknowledge this study’s limitations. Foremost, these results should be interpreted with 
caution because they reflect only the data of individuals who completed the PAM and 
Parent-PAM at the six month assessment period (N=139). Moreover, individuals who did 
not complete the PAM and Parent-PAM (N=59) were more likely to have lower income and 
public insurance; as discussed, these factors have been shown to predict lower activation in 
other populations [22]. Although we did not find that data were MNAR, further studies are 
required to specifically address parent activation in populations with less financial resources 
over time. Further validation studies of the Parent-PAM in parents of children with other 
illnesses would also guide researchers in determining whether or not our results are 
generalizable across populations.
In sum, we reveal the collage of factors associated with parent activation in a population of 
parents as they negotiate the first six months after pediatric HSCT. Many interventions focus 
on changing an individual’s activation or self-efficacy regarding a particular chronic 
condition, but may ignore clinical, social, and perspective changes, which may influence the 
Pennarola et al. Page 9













individual’s ability to manage their child’s care. Our results suggest that adaptive 
interventions for improving parent activation, which respond to pertinent events, may be 
indicated in some populations. For example, in the context of pediatric HSCT, parents of a 
child with a short duration of illness prior to HSCT might require additional support initially 
concerning the importance of their role in caring for their child. In the six months after 
HSCT, parents who have poor emotional functioning or lost private insurance coverage 
might receive greater benefit from efforts to improve activation. Potentially, our results call 
for much greater attention to activation in ill populations with a rapidly fluctuating clinical 
course and the central role parent caregivers play for their ill children.
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Fig. 1. Factors with Changing Effects on Parent-PAM Scores Over Time
Note: Mean parent emotional functioning at baseline was 50 (SD=20); mean log duration of 
illness was 2.7 (SD=1.2). Other factors set to reference or mean value.
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Table 1
Baseline demographic and clinical characteristics of HSCT recipients and their parents
Mean (SD) or n (%) or median (25th–75th percentile)
Parent Demographic Characteristics
Age in years, mean (SD) 38.5 (7.9)
Gender, n (%)
 Female 162 (81.8%)
 Male 36 (18.2%)
Race/ethnicity, n (%)
 White, Non-Hispanic 138 (71.5%)
 Non-White, Non-Hispanic 25 (13.0%)
 Hispanic 30 (15.5%)
Education level, n (%)
 High school graduate or less 54 (27.3%)
 Some college or more 144 (72.7%)
Marital status, n (%)
 Married/Living with partner 166 (83.8%)
 Divorced/separated/widowed 24 (12.1%)
 Never married 8 (4.0%)
Household income, n (%)
 <$40K 66 (33.5%)
 $40K–$59K 31 (15.7%)
 $60K–$79K 27 (13.7%)
 >$80K 73 (37.1%)
Primary caregiver’s job status, n (%)
 Full-time 88 (44.4%)
 Part-time 22 (11.1%)
 Homemaking 88 (44.4%)
Child Demographic Characteristics
Age in years, mean (SD) 8.7 (5.7)
Gender, n (%)
 Female 87 (43.9%)
 Male 111 (56.1%)
Insurance type at baseline, n (%)
 Private 134 (68.0%)
 Public 63 (32.0%)
Clinical Characteristics
Duration of illness in months, median (25th–75th percentile) 11 (6–41)
Causal Diagnosis, n (%)
 Non-malignancy 76 (38.4%)
 Malignancy, no prior relapse 77 (38.9%)
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Mean (SD) or n (%) or median (25th–75th percentile)
 Malignancy, prior relapse 45 (22.7%)
Site of pre-transplant care, n (%)
 Local, at transplant site 79 (40.3%)
 Referred from another institution 117 (59.7%)
Transplant type, n (%)
 Autologous 50 (25.3%)
 Allogeneic-related 38 (19.2%)
 Allogeneic-unrelated 110 (55.6%)
Prior HSCT, n (%) 9 (4.6%)
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Table 2
Univariate and multivariable repeated measures analysis for Parent Activation (Parent-PAM) in 6 months 
following HSCT
Univariate Multivariablea
β (se) p-value β (se) p-value
Time
 Baseline (reference)
 6 months 5.00 (1.29) 0.0001 4.76 (4.65) 0.31
Baseline Parent and Child
Demographic Characteristics
Parent age −0.29 (0.12) 0.02 −0.29 (0.12) 0.02
Parent’s education level
 High school graduate or less (reference)
 Some college or more −1.61 (2.22) 0.47
Marital Status
 Married/living with partner (reference)
 Divorced/separated/widowed −3.01 (2.92) 0.30 −3.0 (2.92) 0.31
 Never married 16.13 (5.13) 0.002 12.27 (5.50) 0.03
Child age −0.11 (0.17) 0.53
Parent Well-being at Time of Assessment
Parent emotional functioning −0.01 (0.05) 0.78 −0.002 (0.05) 0.96
Time*Parental emotional functioning 0.15 (0.07) 0.02 0.14 (0.06) 0.03
Parent general health −0.01 (0.04) 0.70
Parent social support 0.07 (0.05) 0.16
Time* Parent social support −0.01 (0.06) 0.86




 Malignancy, no prior relapse −6.42 (2.20) 0.004
 Malignancy, prior relapse −3.11 (2.55) 0.22
Log duration of illness in months 3.23 (0.87) 0.0003 3.29 (0.88) 0.0002
Time*Log duration of illness in months −3.01 (1.01) 0.003 −2.40 (0.98) 0.02
Transplant type
 Autologous −1.71 (2.35) 0.47
 Allogeneic-related −4.54 (2.60) 0.08
 Allogeneic-unrelated (reference)
Uncontrollable Difficulty of Transplant
Early complicationsb 3.02 (2.26) 0.18
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Univariate Multivariablea
β (se) p-value β (se) p-value
Time*Early complications 1.12 (2.70) 0.68
CGVHDc 0.12 (2.93) 0.97
Time*CGVHD −2.80 (3.34) 0.40
Infection d 2.36 (2.41) 0.33
Time*Infection −0.29 (2.84) 0.92
Parent rating of child’s general health at time of assessment 0.01 (0.03) 0.72
Drop in insurancee 5.30 (4.81) 0.27 2.95 (4.65) 0.53
Time*Drop in insurance −14.48 (4.84) 0.003 −13.82 (4.68) 0.004
a
Multivariable model controls for HSCT-CHESS intervention
b
aGVHD of grade 2 or higher or intermediate or poor toxicity by 3 months
c
Limited or extensive cGVHD by 6 months
d
Systemic Infection by 6 months
e
Change from private insurance at baseline to public insurance at six months
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